ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:54 am Purchase | 2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,466,420 9.150% | 2,516,420 (+129.05%) | Filing |
| 2022-02-10 09:13 am Purchase | 2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,950,000 5.750% | 450,000 (+30.00%) | Filing |
| 2021-02-12 4:06 pm Purchase | 2021-02-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,500,000 5.230% | 1,500,000 (New Position) | Filing |